Some petroclival meningiomas cause trigeminal nerve compression leading to disabling trigeminal neuralgia. Tumor resection and nerve decompression can offer pain relief but may not be feasible in all patients. Simultaneous stereotactic radiosurgery (SRS) to the tumor and nerve is another option. It is an effective means of treating meningiomas and trigeminal neuralgia separately, but there is limited data regarding the efficacy and outcomes of their concomitant treatment.We present our series of four patients who presented with trigeminal neuralgia secondary to a petroclival mass causing compression of the trigeminal nerve. All patients underwent SRS to both the petroclival mass and trigeminal nerve in a single-session. The average margin tumor dose was 12.25Gy (range, 12 to 12.5Gy) and average maximum trigeminal nerve dose was 80Gy (range, 75 to 85Gy). Barrow Neurologic Institute (BNI) Pain Intensity Scores in all patients prior to intervention were a grade IV or V. At last follow-up (average = 29.8 months), all patients were pain free (BNI I or IIIA). Two patients experienced reduced facial sensation in either one or all three distributions. No brainstem edema was seen.This series highlights the benefit and safety of simultaneous treatment of petroclival tumors and the trigeminal nerve in a single session for patients affected by tumor related trigeminal neuralgia.